Status:

COMPLETED

eRT Remote Health Monitoring

Lead Sponsor:

University of California, Los Angeles

Collaborating Sponsors:

eResearch Technology (eRT)

Conditions:

Pulmonary Disease, Chronic Obstructive

COPD

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

Remote Health Monitoring (RHM) is the assessment of one's own symptoms at home between doctor visits, using things like at-home breathing tests, electronic diaries to answer questionnaires, and other ...

Eligibility Criteria

Inclusion

  • Age \>40 years.
  • Clinical diagnosis of moderate to severe COPD in accordance with the definition of the American Thoracic Society (ATS).9
  • Smoking history \>10 pack-years.
  • Postbronchodilator FEV1/FVC\<70% and FEV1\<70% based on NHANES III reference values
  • Domestic situation felt to be supportive of remote health monitoring.
  • Ability to give informed consent.

Exclusion

  • Clinical diagnosis of asthma.
  • Pulmonary disease other than COPD (e.g., lung cancer, sarcoidosis, active tuberculosis, bronchiectasis, pulmonary fibrosis, cystic fibrosis, or alpha-1-antitrypsin deficiency) or had lung volume reduction.
  • Any other active disease that, in the opinion of the investigator, would put the safety of the subject at risk through study participation (e.g. unstable cardiovascular disease, renal failure, stroke).
  • Previously diagnosed cancer is considered a significant disease unless it is in complete remission for 2 years at the initial visit.
  • Any other disease that is life-threatening and carries a prognosis less than two years that, in the opinion of the investigator, is likely to influence the clinical course during the conduct of this trial.
  • Myocardial infarction within 6 weeks of enrolment.
  • Use of long-term oxygen therapy (LTOT) prescribed for greater than 12 hours a day.
  • A known or suspected history of drug or alcohol abuse within 2 years prior to the initial visit.

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 20 2014

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT01495780

Start Date

January 1 2012

End Date

August 20 2014

Last Update

May 1 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCLA David Geffen School of Medicine

Los Angeles, California, United States, 90095